Drug Trial Radar · NCT06095115
A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis
Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
684
Actual
Start
Oct 12, 2023
Primary completion
Jul 29, 2024
Study completion Apr 6, 2027
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Oct 23, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is see how effective is JNJ-77242113 in participants with moderate to severe plaque psoriasis.
Conditions
- Plaque Psoriasis
Interventions
JNJ-77242113Drug
JNJ-77242113 will be administered orally.
PlaceboDrug
Placebo will be administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Achieved an Investigator's Global Assessment (IGA) Score of 0 or 1 and Greater Than or Equal to (>=) 2-Grade Improvement From Baseline at Week 16Time frame: Week 16
- Percentage of Participants Who Achieved Psoriasis Area and Severity Index (PASI) 90 Response at Week 16Time frame: Week 16
Locations
170 sites in 16 countries. Site status is shown where the registry gives one.
Medical Dermatology Specialists
Phoenix, Arizona
Johnson Dermatology
Fort Smith, Arkansas
First OC Dermatology
Fountain Valley, California
Center for Dermatology Clinical Research
Fremont, California
Integrative Skin Science and Research
Sacramento, California
Rady Childrens Hospital San Diego
San Diego, California
Southern California Dermatology
Santa Ana, California
Clinical Science Institute
Santa Monica, California
Bioclinical Research Alliance Inc.
Miami, Florida
Ziaderm Research LLC
North Miami Beach, Florida
Forcare Clinical Research Inc
Tampa, Florida
Skin Care Physicians of Georgia
Macon, Georgia
Arlington Dermatology
Rolling Meadows, Illinois
Endeavor Health
Skokie, Illinois
Dundee Dermatology
West Dundee, Illinois
Dawes Fretzin Clinical Research Group LLC
Indianapolis, Indiana
Indiana Clinical Trial Center
Plainfield, Indiana
Qualmedica Research
Owensboro, Kentucky
Dermatology and Advanced Aesthetics
Lake Charles, Louisiana
Allcutis Research 1
Beverly, Massachusetts
Michigan Center of Medical Research
Clarkston, Michigan
Minnesota Clinical Study Center
New Brighton, Minnesota
Skin Specialists
Omaha, Nebraska
Allcutis Research
Portsmouth, New Hampshire
Schweiger Dermatology Group
East Windsor, New Jersey
Icahn School of Medicine at Mt. Sinai
New York, New York
Wilmington Dermatology Center
Wilmington, North Carolina
Oakview Dermatology
Athens, Ohio
Optima Research
Boardman, Ohio
Pharmacology Translational Unit PTU Fairborn LLC
Fairborn, Ohio
Central Sooner Research
Oklahoma City, Oklahoma
Oregon Medical Research Center
Portland, Oregon
Oregon Dermatology and Research Center
Portland, Oregon
The Pennsylvania Centre for Dermatology, LLC
Exton, Pennsylvania
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
Medical University of South Carolina
Charleston, South Carolina
Health Concepts
Rapid City, South Dakota
Arlington Research Center, Inc.
Arlington, Texas
The University of Texas Health Science Center at Houston
Bellaire, Texas
Center for Clinical Studies 1
Houston, Texas
Showing 40 of 170 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.